Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 38.2633.6826.0334.4025.13

What is the latest EV/EBIT ratio of TORRENT PHARMACEUTICALS ?

The latest EV/EBIT ratio of TORRENT PHARMACEUTICALS is 38.26 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202538.26
Mar202433.68
Mar202326.03
Mar202234.40
Mar202125.13

How is EV/EBIT of TORRENT PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 38.26
13.60
Mar2024 33.68
29.39
Mar2023 26.03
-24.33
Mar2022 34.4
36.89
Mar2021 25.13 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/EBIT ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹148,852.0 Cr 4.5% 10% 41.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics
MANKIND PHARMA ₹84,767.5 Cr -1.1% -2% -14.3% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

4.5%

10%

41.5%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses